These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30787537)

  • 41. Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial.
    Zhang H; Liu ZL; Sun P; Gu F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):615-21. PubMed ID: 21823986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PHARMACOLOGICAL INTRAVITREAL TREATMENT FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION - THREE-MONTH RESULTS.
    Karadžić J; Kovačević I; Ljikar J; Grgić Z; Devečerski G
    Med Pregl; 2015; 68(9-10):295-300. PubMed ID: 26727825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreous ranibizumab for persistent macular edema in retinal vein occlusion unresponsive to bevacizumab.
    De Niro JE; Fu AD; Johnson RN; McDonald HR; Jumper JM; Cunningham E; Lujan BJ
    Retin Cases Brief Rep; 2013; 7(3):220-4. PubMed ID: 25391110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
    Gokce G; Sobaci G; Durukan AH; Erdurman FC
    Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. QUIESCENT HERPES SIMPLEX KERATITIS REACTIVATION AFTER INTRAVITREAL INJECTION OF DEXAMETHASONE IMPLANT.
    Jusufbegovic D; Schaal S
    Retin Cases Brief Rep; 2017 Fall; 11(4):296-297. PubMed ID: 27508424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of treatment response to intravitreal injection of triamcinolone, bevacizumab and combined form in patients with central retinal vein occlusion: A randomized clinical trial.
    Motarjemizadeh G; Rajabzadeh M; Aidenloo NS; Valizadeh R
    Electron Physician; 2017 Aug; 9(8):5068-5074. PubMed ID: 28979743
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uveo-meningeal syndrome secondary to Herpes Simplex Virus related acute retinal necrosis.
    Haghnegahdar M; Pennipede D; Massey B; Champion M; Ajlan R
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101409. PubMed ID: 35198826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SCORE2 Report 2: Study Design and Baseline Characteristics.
    Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; Figueroa M; Dugel PU;
    Ophthalmology; 2017 Feb; 124(2):245-256. PubMed ID: 27863843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion.
    Hirose M; Matsumiya W; Honda S; Nakamura M
    Clin Ophthalmol; 2014; 8():2301-5. PubMed ID: 25429200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
    Bakri SJ; Omar AF
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).
    Algvere PV; Von Wendt G; Gudmundsson J; Seregard S; Kvanta A
    Acta Ophthalmol; 2010 Dec; 88(8):836-41. PubMed ID: 19900206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kyrieleis Arteriolitis Associated with Acute Retinal Necrosis due to Herpes Simplex Virus Type 1 Secondary to Herpetic Encephalitis.
    Makri OE; Tsekouras IK; Leonidou L; Kagkelaris K; Kozobolis V; Georgakopoulos CD
    Vision (Basel); 2022 May; 6(2):. PubMed ID: 35645381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion.
    Hung KH; Lee SM; Lee SY; Lee FL; Yang CS
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):85-90. PubMed ID: 20148661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up).
    Kornhauser T; Schwartz R; Goldstein M; Neudorfer M; Loewenstein A; Barak A
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):835-44. PubMed ID: 26269374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Lee KH; Kang EC; Koh HJ
    Korean J Ophthalmol; 2017 Apr; 31(2):108-114. PubMed ID: 28367038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion.
    Tao Y; Hou J; Jiang YR; Li XX; Jonas JB
    Eye (Lond); 2010 May; 24(5):810-5. PubMed ID: 19696805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination of Intravitreal Corticosteroid with Anti-vegf in Macular Edema Secondary to Retinal Vein Occlusion.
    Valašková J; Popov I; Krásnik V
    Cesk Slov Oftalmol; 2018; 73(5-6):183-188. PubMed ID: 30541298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.